A randomized, Multi-center, Parallel, 3- group case study to evaluate tumor reduction with safety and efficacy of study drug (i) AB001 along with Chemotherapy, (ii) AB001, (iii) Ongoing regular Chemotherapy in patients with various types of Metastatic Cancer â?? Study - -
Start Date17 Jan 2022
Sponsor / Collaborator-
100 Clinical Results associated with APRIL x AR x BAFF x PDL1 x STAT3
Login to view more data
100 Translational Medicine associated with APRIL x AR x BAFF x PDL1 x STAT3
Login to view more data
0 Patents (Medical) associated with APRIL x AR x BAFF x PDL1 x STAT3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.